University of Massachusetts Medical School
Surgical Outcomes Analysis & Discretion (SOAR)
Clinical, Translational, and Outcomes Discretion
Surgical Outcomes Analysis & Discretion (SOAR) investigates surgical diseases and perioperative outcomes. Our group focuses on pancreatic cancer as well as other gastrointestinal and hepatobiliary malignancies. Our goal is to examine quality, delivery, and financing of care in order to have an immediate impact on patient care and system improvements. We utilize national health services and administrative databases, as well as prospective institutional tissue-linked databases, to investigate and to address factors contributing to disease outcomes and healthcare disparities.
Our work incorporates advanced statistical techniques, including logistic regression, prediction score, and decision analysis modeling. Additionally, we participate in groundbreaking pancreatic cancer biomarker discovery. With rigorous proteomic assessment of blood, bile, and pancreatic fluid, we aspire to utilize biomarkers that will enable early diagnosis of pancreatic cancer and reliably predict patient response to treatment.
We welcome and appreciate your interest and inquiries.